Drugs for livestock can harm beneficial organisms that break down dung. Therefore newly developed medical substances need to be tested on single species in the lab. An international research group including evolutionary biologists from the University of Zurich have been scrutinizing the reliability of such laboratory tests, evaluating the implementation of a field test based on the anti-parasitic drug ivermectin at four climatically different locations. The scientists thus presented a novel approach for more advanced environmental compatibility tests.
Livestock medications can impair beneficial organisms that break down dung. Too high a dosage of ivermectin, a common drug against parasites, harms coprophilous organisms, for instance. The toxicity of new livestock medications therefore needs to be verified in ecotoxicological tests with individual animal species such as the common yellow dung fly, the barn fly or a dung beetle.
This involves determining the lethal dose leading to the death of half the maggots (LD50 test). However, sensitivity to toxic substances is known to vary significantly even among closely related coprophilous organisms, which begs the question as to how representative the reaction of any individual animal species actually is in such laboratory tests. After all, there is a high risk that more sensitive species will continue to be harmed by the substance, jeopardizing key ecosystem functions in the long run.
An international research group including UZH evolutionary biologist Wolf Blanckenhorn recently proposed extending the testing scheme to a representative selection of all organisms that break down dung, ideally in their natural environment. The scientists now presented a successful and more comprehensive higher-tier ecotoxicological field test. Their study provides important insights into minimizing the risks of drug residues in nature.
Earthworms compensate for loss of coprophilous insects
For their feasibility study, the scientists worked on cattle pastures in the Canadian Prairie and the agricultural landscapes of southern France, the Netherlands and Switzerland – four locations with very different climatic conditions. On these pastures, they distributed dung pats with different concentrations of ivermectin. “As expected, the overall number and diversity of dung beetles, dung flies and parasitoid wasps decreased as the ivermectin concentration increased,” explains Blanckenhorn.
However, a number of species also proved to be resistant: earthworms and springtails living in the ground underneath the cowpats were not notably affected, and a parallel test ultimately revealed that dung degradation was not significantly impaired. “Evidently, beneficial organisms not affected as much by the drug, such as earthworms, were apparently able to compensate for the loss of other organisms,” sums up Blanckenhorn.
A basis for decision makers and licensing authorities
Despite diverse environmental conditions and methodological details, the results were very similar and reproducible in all four habitats. “Our field approach was therefore a success and in principle can be recommended. The regulation authorities responsible, such as the European Medicines Agency EMA, now have to decide whether this more conclusive yet more complex test should be required in the future,” says Blanckenhorn.
The amount of effort involved in determining the numerous dung organisms is tremendous and impossible without expert biological knowledge. “Classifying species via so-called DNA barcoding, based on each organism’s unique genetic fingerprint, is possible in principle and will probably be more cost-effective in the future. However, this approach requires the establishment of a complete database for coprophilous organisms, which does not yet exist,” concludes the scientist.
Kevin D. Floate, Wolf U. Blanckenhorn. Special Section: Non-target Structural and Functional Effects of Ivermectin Residues in Cattle Dung on Pasture – Guidance for Researchers and Regulators. Environmental Toxicology and Chemistry. Volume 35, Issue 8. July 21, 2016. DOI: 10.1002/etc.3549
Scientists discovered and refined ivermectin in Japan in the mid-1970s, eventually winning the Nobel Prize in Medicine in 2015. The drug has been used to cure river blindness, scabies and roundworms in the gut of humans, as well as parasites in livestock and pets.
Chemically ivermectin belongs to the avermectins, which generally interfere with ion channel transport through the cell membrane and thus the molting of pest organisms. If the ivermectin dosage is too high and excreted in the feces of treated livestock, the drug also kills beneficial organisms that break down dung. This has a negative impact on the functioning of the entire ecosystem: in extreme cases, the dung is no longer degraded at all and the pasture cannot be used any further.
Prof. Dr. Wolf U. Blanckenhorn
Department of Evolutionary Biology and Environmental Studies
University of Zurich
Phone: +41 44 635 47 55
University of Zurich
Phone: +41 44 634 44 67
Nathalie Huber | Universität Zürich
Listening in: Acoustic monitoring devices detect illegal hunting and logging
14.12.2017 | Gesellschaft für Ökologie e.V.
How fires are changing the tundra’s face
12.12.2017 | Gesellschaft für Ökologie e.V.
DNA molecules that follow specific instructions could offer more precise molecular control of synthetic chemical systems, a discovery that opens the door for engineers to create molecular machines with new and complex behaviors.
Researchers have created chemical amplifiers and a chemical oscillator using a systematic method that has the potential to embed sophisticated circuit...
MPQ scientists achieve long storage times for photonic quantum bits which break the lower bound for direct teleportation in a global quantum network.
Concerning the development of quantum memories for the realization of global quantum networks, scientists of the Quantum Dynamics Division led by Professor...
Researchers have developed a water cloaking concept based on electromagnetic forces that could eliminate an object's wake, greatly reducing its drag while...
Tiny pores at a cell's entryway act as miniature bouncers, letting in some electrically charged atoms--ions--but blocking others. Operating as exquisitely sensitive filters, these "ion channels" play a critical role in biological functions such as muscle contraction and the firing of brain cells.
To rapidly transport the right ions through the cell membrane, the tiny channels rely on a complex interplay between the ions and surrounding molecules,...
The miniaturization of the current technology of storage media is hindered by fundamental limits of quantum mechanics. A new approach consists in using so-called spin-crossover molecules as the smallest possible storage unit. Similar to normal hard drives, these special molecules can save information via their magnetic state. A research team from Kiel University has now managed to successfully place a new class of spin-crossover molecules onto a surface and to improve the molecule’s storage capacity. The storage density of conventional hard drives could therefore theoretically be increased by more than one hundred fold. The study has been published in the scientific journal Nano Letters.
Over the past few years, the building blocks of storage media have gotten ever smaller. But further miniaturization of the current technology is hindered by...
11.12.2017 | Event News
08.12.2017 | Event News
07.12.2017 | Event News
15.12.2017 | Power and Electrical Engineering
15.12.2017 | Materials Sciences
15.12.2017 | Life Sciences